Replies to post #2457 on Innolife Pharma Inc.(fka INNP)

[roiresearch]

It is a difficult debate

I think it's a volatile stock

200 million shares in the float at .001 - .002 is a very easy thing to dry up with very little money

500 o/s vs. 600 a/s

CEO says nothing has changed in the business plan to warrant the declining PPS - worse case scenario is 600 million o/s, with 300 million in the float. Still not a bad thing.

I don't know if the t/a is gagged or just is lazy. Seen both situations in the past

CEO has been defiant regarding the share price and dilution in the past. Will she change her story? Don't know...but ALRX has had to issue similar PRs and their capital structure hasn't been diluted either.